• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

AVEO Pharmaceuticals Inc - Articles and news items

tivozanib

MAA submitted for tivozanib for the treatment of RCC

Industry news / 1 March 2016 / Victoria White

Tivozanib is an oral, once-daily, vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI)…

tivozanib

AVEO receives European regulatory guidance regarding potential marketing authorisation application for tivozanib

Industry news / 4 June 2015 / Victoria White

AVEO has received confirmation of support from two CHMP members following pre-submission meetings to discuss the potential submission of a MAA for tivozanib…

Astellas logo
Boehringer Ingelheim logo

Boehringer Ingelheim and AVEO announce manufacturing agreement for ficlatuzumab

Industry news, News / 1 December 2011 / Boehringer Ingelheim

AVEO & Boehringer Ingelheim enter into an agreement…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +